Screener
Cogent Biosciences, Inc. COGT Increase Decrease In Operating Leases
Increase Decrease In Operating Leases at other companies
Other financials
Where this comes from
Reported directly by Cogent Biosciences, Inc. in its filing.
Tagged under the XBRL concept cogt:IncreaseDecreaseInOperatingLeases.
The source filing: Cogent Biosciences, Inc.’s 10-Q, filed August 10, 2026. Open the filing →
- Filed
- Aug 10, 2026, 4:11 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-342393
FAQ
- What is Cogent Biosciences, Inc.'s increase decrease in operating leases?
- Cogent Biosciences, Inc. (COGT) reported increase decrease in operating leases of -$351K in Q2 2026.
- How has Cogent Biosciences, Inc.'s increase decrease in operating leases changed year-over-year?
- Cogent Biosciences, Inc.'s increase decrease in operating leases increased by 8.1% year-over-year, from -$382K to -$351K.
- What is the long-term trend for Cogent Biosciences, Inc.'s increase decrease in operating leases?
- Over 4 years (2021 to 2025), Cogent Biosciences, Inc.'s increase decrease in operating leases has grown at a -6.5% compound annual growth rate (CAGR), from -$2.05M to -$1.57M.
- What does increase decrease in operating leases mean?
- Increase Decrease In Operating Leases as reported by Cogent Biosciences, Inc. Common Stock.
Ask your AI about Cogent Biosciences, Inc.'s increase decrease in operating leases.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude